Erxiantongguan Decoction post-menopausal women with recurrent urinary tract infections.docVIP
- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Erxiantongguan Decoction post-menopausal women with recurrent urinary tract infections
PAGE \* MERGEFORMAT 10
Erxiantongguan Decoction post-menopausal women with recurrent urinary tract infections
【Abstract】 In order to observe the effects of Erxiantongguan Tang treatment of postmenopausal women, urinary tract infection efficacy in 68 patients were randomly divided into treatment group of 35 cases and 33 cases of the control group and treatment group was given Erxiantongguan soup, and the control group was treated with norfloxacin, 8 weeks for a course of treatment. The results showed that Erxiantongguan Tang can significantly improve the clinical symptoms, reduce relapse, effective than norfloxacin.
Keywords: Erxiantongguan Tang prescription recurrent urinary tract infections
Composition of Erxiantongguan Tang
Composition: Zhimu 15g, Treats 15g, cinnamon 10g, Curculigoside 10g, Epimedium 10g, antler pieces 10g, Morinda 15g, talc 30g, Chinese angelica 10g, licorice root 5g, Plantago (bag) 30g, Wang does not stay in line 30g, Zhuling 30g, Shi Wei 15g, red peony 15g, peach kernel 10g.
Modified: Urinary tract irritation severe Kaki pass 5g, bamboo 10g, a see-hi 10g; dribbling urine who gav medicine 15g, Money Grass 30g; abdominal pain plus red peony root of all those who 15g, aloe tablets 3g .
Usage: water Jianzhi two times, each time juice 200ml, sooner or later taking the points, a total of 8 weeks.
Clinical
General Information: 68 patients were from 2001 to 2005 in our hospital out-patient treatment of patients, their inclusion and exclusion criteria: (1) With reference to the Second National Conference on development of kidney disease with recurrent urinary tract infection in diagnostic criteria [1 ]; (2) are postmenopausal women; (3) TCM Syndrome typing is kidney yin deficiency, hot and humid intrinsic persons; (4) to exclude urinary tract infection in diabetes mellitus, renal insufficiency, urinary tract stones were. 68 cases were randomly divided into treatment group and control grou
您可能关注的文档
- Epichlorohydrin for tissue engineering heart valve 1,3 in matrix metalloproteinase expression in.doc
- Epidemiological Analysis of HIV infection among drug users.doc
- Ephedrine Extraction Process.doc
- Epidemic cerebrospinal meningitis case-fatality rate of Markov Prediction Model.doc
- Epidemiological investigation of 282 cases of childhood burns and preventive measures.doc
- Epidemiological features of 289 cases of measles and case analysis.doc
- Epidemiological investigation of senile hypertension pastoralists and intervention.doc
- Epidemic encephalitis IL-1 neuron-specific enolase and its clinical significance.doc
- Epidemiological characteristics of TB Prevention and Control Force.doc
- Epidemiological studies of senile dementia status.doc
- Erythromycin on rat model of chronic obstructive pulmonary disease airway inflammation.doc
- Erythromycin on peripheral blood mononuclear cells in asthmatic rats phosphorylation of JNK expression.doc
- Erythropoietin and cerebral ischemic injury.doc
- Erythropoietin on A25 ~ 35 cells induced by nerve injury in vitro.doc
- Erythropoietin on neonatal hypoxic ischemic encephalopathy in serum SOD NO levels.doc
- Erythropoietin on the retinal optic nerve protective effect of.doc
- Erythropoietin on hemodynamics in rats with myocardial infarction and infarct size of.doc
- Erythropoietin potential protective effects of progress.doc
- ESBLs producing bacteria in elderly patients with pulmonary infection and drug resistance survey.doc
- Erythropoietin (EPO) in liver ischemia-reperfusion injury (HIRI) The role of.doc
文档评论(0)